BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50337318 CC(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H34F3N5O4/c1-20(40)37-15-12-26-25(18-37)30(21-6-8-22(9-7-21)31(32,33)34)35-38(26)17-24(41)16-36-13-10-23(11-14-36)39-27-4-2-3-5-28(27)43-19-29(39)42/h2-9,23-24,41H,10-19H2,1H3 SGSPOYZDDMQIAD-UHFFFAOYSA-N 50182087 4-(1-(3-(5-acetyl-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL205919 HLA class II histocompatibility antigen gamma chain Homo sapiens 1100 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182087&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10304088 104066877 CHEMBL205919 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337319 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCN(CC1)c1ccnc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H33F3N6O3S/c1-43(41,42)38-13-11-28-25(20-38)29(21-6-8-22(9-7-21)30(31,32)33)35-39(28)19-23(40)18-36-14-16-37(17-15-36)27-10-12-34-26-5-3-2-4-24(26)27/h2-10,12,23,40H,11,13-20H2,1H3 ACOYYVDPMMDIFE-UHFFFAOYSA-N 50182088 1-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-3-(4-(quinolin-4-yl)piperazin-1-yl)propan-2-ol::CHEMBL381271 Cathepsin S Homo sapiens 1700 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182088&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44410206 104066878 CHEMBL381271 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337320 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1c2ccc(Cl)cc2CNS1(=O)=O)-c1ccc(Br)cc1 InChI=1S/C28H34BrClN6O5S2/c1-42(38,39)34-13-10-27-25(18-34)28(19-2-4-21(29)5-3-19)32-35(27)17-24(37)16-33-11-8-23(9-12-33)36-26-7-6-22(30)14-20(26)15-31-43(36,40)41/h2-7,14,23-24,31,37H,8-13,15-18H2,1H3 CWFWXRMDPPNMFG-UHFFFAOYSA-N 50182089 1-[3-(4-Bromo-phenyl)-5-methanesulfonyl-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-3-[4-(6-chloro-2,2-dioxo-3,4-dihydro-2H-2lambda*6*-benzo[1,2,6]thiadiazin-1-yl)-piperidin-1-yl]-propan-2-ol::CHEMBL379770 Cathepsin S Homo sapiens 75 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182089&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44410075 104066879 CHEMBL379770 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337321 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1c2ccc(Cl)cc2CNS1(=O)=O)-c1ccc(Br)cc1 InChI=1S/C28H34BrClN6O5S2/c1-42(38,39)34-13-10-27-25(18-34)28(19-2-4-21(29)5-3-19)32-35(27)17-24(37)16-33-11-8-23(9-12-33)36-26-7-6-22(30)14-20(26)15-31-43(36,40)41/h2-7,14,23-24,31,37H,8-13,15-18H2,1H3 CWFWXRMDPPNMFG-UHFFFAOYSA-N 50182089 1-[3-(4-Bromo-phenyl)-5-methanesulfonyl-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-3-[4-(6-chloro-2,2-dioxo-3,4-dihydro-2H-2lambda*6*-benzo[1,2,6]thiadiazin-1-yl)-piperidin-1-yl]-propan-2-ol::CHEMBL379770 HLA class II histocompatibility antigen gamma chain Homo sapiens 2700 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182089&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 44410075 104066879 CHEMBL379770 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337322 CC(C)(C)OC(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C34H40F3N5O5/c1-33(2,3)47-32(45)40-17-14-27-26(20-40)31(22-8-10-23(11-9-22)34(35,36)37)38-41(27)19-25(43)18-39-15-12-24(13-16-39)42-28-6-4-5-7-29(28)46-21-30(42)44/h4-11,24-25,43H,12-21H2,1-3H3 JGSIEANYYGCVKS-UHFFFAOYSA-N 50182090 tert-butyl 1-(2-hydroxy-3-(4-(3-oxo-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)piperidin-1-yl)propyl)-3-(4-(trifluoromethyl)phenyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate::CHEMBL382419 Cathepsin S Homo sapiens 826 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182090&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10233328 104066880 CHEMBL382419 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337323 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H33ClF3N5O4S/c1-44(41,42)37-16-11-25-24(18-37)29(20-3-5-21(6-4-20)30(32,33)34)35-38(25)13-2-12-36-14-9-23(10-15-36)39-26-17-22(31)7-8-27(26)43-19-28(39)40/h3-8,17,23H,2,9-16,18-19H2,1H3 SRBWXNQHBPHNCM-UHFFFAOYSA-N 50182091 6-chloro-4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL206722 Cathepsin S Homo sapiens 130 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182091&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10283088 104066881 CHEMBL206722 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337324 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34F3N5O5S/c1-44(41,42)36-15-12-25-24(18-36)29(20-6-8-21(9-7-20)30(31,32)33)34-37(25)17-23(39)16-35-13-10-22(11-14-35)38-26-4-2-3-5-27(26)43-19-28(38)40/h2-9,22-23,39H,10-19H2,1H3 AMSFCNUCSFWCJW-UHFFFAOYSA-N 50182092 4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL201461 Cathepsin S Homo sapiens 28 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182092&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10168223 104066882 CHEMBL201461 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337325 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)OCc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34F3N5O5S/c1-44(41,42)36-15-12-27-25(18-36)28(20-6-8-22(9-7-20)30(31,32)33)34-37(27)17-24(39)16-35-13-10-23(11-14-35)38-26-5-3-2-4-21(26)19-43-29(38)40/h2-9,23-24,39H,10-19H2,1H3 CPKFDNOZJRILFT-UHFFFAOYSA-N 50182093 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-1H-benzo[d][1,3]oxazin-2(4H)-one::CHEMBL381369 HLA class II histocompatibility antigen gamma chain Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182093&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293649 104066883 CHEMBL381369 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337326 Cc1cccc2OCC(=O)N(C3CCN(CCCn4nc(c5CN(CCc45)S(C)(=O)=O)-c4ccc(cc4)C(F)(F)F)CC3)c12 InChI=1S/C31H36F3N5O4S/c1-21-5-3-6-27-30(21)39(28(40)20-43-27)24-11-16-36(17-12-24)14-4-15-38-26-13-18-37(44(2,41)42)19-25(26)29(35-38)22-7-9-23(10-8-22)31(32,33)34/h3,5-10,24H,4,11-20H2,1-2H3 RESXFZPYLTYNJX-UHFFFAOYSA-N 50182094 5-methyl-4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL379351 HLA class II histocompatibility antigen gamma chain Homo sapiens 2000 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182094&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10189472 104066884 CHEMBL379351 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337327 OC(CN1CCC(CC1)N1C(=O)COc2ccccc12)Cn1nc(c2CNCCc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C29H32F3N5O3/c30-29(31,32)20-7-5-19(6-8-20)28-23-15-33-12-9-24(23)36(34-28)17-22(38)16-35-13-10-21(11-14-35)37-25-3-1-2-4-26(25)40-18-27(37)39/h1-8,21-22,33,38H,9-18H2 MZGWUWFJBFMLKV-UHFFFAOYSA-N 50182096 4-(1-(2-hydroxy-3-(3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL426309 Cathepsin S Homo sapiens 1925 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182096&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293858 104066886 CHEMBL426309 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337328 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H35F3N6O4S/c1-44(42,43)37-15-12-27-25(19-37)28(20-6-8-22(9-7-20)30(31,32)33)35-38(27)18-24(40)17-36-13-10-23(11-14-36)39-26-5-3-2-4-21(26)16-34-29(39)41/h2-9,23-24,40H,10-19H2,1H3,(H,34,41) WYSKAEXCXYHGLH-UHFFFAOYSA-N 50182097 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one::CHEMBL208344 Cathepsin S Homo sapiens 48 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182097&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293909 104066887 CHEMBL208344 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337329 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2cccnc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C29H33F3N6O5S/c1-44(41,42)36-14-10-24-23(17-36)27(19-4-6-20(7-5-19)29(30,31)32)34-37(24)16-22(39)15-35-12-8-21(9-13-35)38-26(40)18-43-25-3-2-11-33-28(25)38/h2-7,11,21-22,39H,8-10,12-18H2,1H3 ANFWDRBSMJXUMQ-UHFFFAOYSA-N 50182098 4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one::CHEMBL239179 Cathepsin S Homo sapiens 80 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182098&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10233020 104066888 CHEMBL239179 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337330 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2cc(Cl)ccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrClN6O4S/c1-42(40,41)35-13-10-27-25(18-35)28(19-2-4-21(30)5-3-19)33-36(27)17-24(38)16-34-11-8-23(9-12-34)37-26-7-6-22(31)14-20(26)15-32-29(37)39/h2-7,14,23-24,38H,8-13,15-18H2,1H3,(H,32,39) MMZSAHKUNZFXRJ-UHFFFAOYSA-N 50182099 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-6-chloro-3,4-dihydroquinazolin-2(1H)-one::CHEMBL206035 HLA class II histocompatibility antigen gamma chain Homo sapiens 1500 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182099&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293722 104066889 CHEMBL206035 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337331 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H35BrN6O4S/c1-41(39,40)34-15-12-27-25(19-34)28(20-6-8-22(30)9-7-20)32-35(27)18-24(37)17-33-13-10-23(11-14-33)36-26-5-3-2-4-21(26)16-31-29(36)38/h2-9,23-24,37H,10-19H2,1H3,(H,31,38) AFUFPTUEAKAICH-UHFFFAOYSA-N 50182095 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one::CHEMBL205748 HLA class II histocompatibility antigen gamma chain Homo sapiens 1100 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182095&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293696 104066885 CHEMBL205748 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337332 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C30H36BrN5O4S/c1-41(39,40)34-17-14-28-26(20-34)30(22-6-9-23(31)10-7-22)32-35(28)19-25(37)18-33-15-12-24(13-16-33)36-27-5-3-2-4-21(27)8-11-29(36)38/h2-7,9-10,24-25,37H,8,11-20H2,1H3 ZGOIFGITJRFQKU-UHFFFAOYSA-N 50182100 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one::CHEMBL208103 Cathepsin S Homo sapiens 33 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182100&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10122216 104066890 CHEMBL208103 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337333 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1c2ccc(Cl)cc2CNS1(=O)=O)-c1ccc(cc1)C(F)(F)F InChI=1S/C29H34ClF3N6O5S2/c1-45(41,42)37-13-10-27-25(18-37)28(19-2-4-21(5-3-19)29(31,32)33)35-38(27)17-24(40)16-36-11-8-23(9-12-36)39-26-7-6-22(30)14-20(26)15-34-46(39,43)44/h2-7,14,23-24,34,40H,8-13,15-18H2,1H3 XLBFTGSAZVJCHG-UHFFFAOYSA-N 50182101 1-[4-(6-Chloro-2,2-dioxo-3,4-dihydro-2H-2lambda*6*-benzo[1,2,6]thiadiazin-1-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol::CHEMBL203102 HLA class II histocompatibility antigen gamma chain Homo sapiens 1300 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182101&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10233786 104066891 CHEMBL203102 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337334 CC(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H34F3N5O3/c1-21(40)37-18-13-26-25(19-37)30(22-7-9-23(10-8-22)31(32,33)34)35-38(26)15-4-14-36-16-11-24(12-17-36)39-27-5-2-3-6-28(27)42-20-29(39)41/h2-3,5-10,24H,4,11-20H2,1H3 DXZBVPJKNGQDSA-UHFFFAOYSA-N 50182102 4-(1-(3-(5-acetyl-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL206745 HLA class II histocompatibility antigen gamma chain Homo sapiens 810 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182102&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10303703 104066892 CHEMBL206745 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337335 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H33ClF3N5O5S/c1-45(42,43)37-13-10-25-24(17-37)29(19-2-4-20(5-3-19)30(32,33)34)35-38(25)16-23(40)15-36-11-8-22(9-12-36)39-26-14-21(31)6-7-27(26)44-18-28(39)41/h2-7,14,22-23,40H,8-13,15-18H2,1H3 PXKDEJBONDAVII-UHFFFAOYSA-N 50182103 6-chloro-4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL414587 Cathepsin S Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182103&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10211864 104066893 CHEMBL414587 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337336 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2cccnc12)-c1ccc(Br)cc1 InChI=1S/C28H33BrN6O5S/c1-41(38,39)33-14-10-24-23(17-33)27(19-4-6-20(29)7-5-19)31-34(24)16-22(36)15-32-12-8-21(9-13-32)35-26(37)18-40-25-3-2-11-30-28(25)35/h2-7,11,21-22,36H,8-10,12-18H2,1H3 JBLOHPBDSXSVNC-UHFFFAOYSA-N 50182104 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one::CHEMBL377511 HLA class II histocompatibility antigen gamma chain Homo sapiens 900 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182104&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293657 104066894 CHEMBL377511 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337337 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2cc(Cl)ccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrClN6O4S/c1-42(40,41)35-13-10-27-25(18-35)28(19-2-4-21(30)5-3-19)33-36(27)17-24(38)16-34-11-8-23(9-12-34)37-26-7-6-22(31)14-20(26)15-32-29(37)39/h2-7,14,23-24,38H,8-13,15-18H2,1H3,(H,32,39) MMZSAHKUNZFXRJ-UHFFFAOYSA-N 50182099 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-6-chloro-3,4-dihydroquinazolin-2(1H)-one::CHEMBL206035 Cathepsin S Homo sapiens 33 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182099&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293722 104066889 CHEMBL206035 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337338 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2cccnc12)-c1ccc(Br)cc1 InChI=1S/C28H33BrN6O5S/c1-41(38,39)33-14-10-24-23(17-33)27(19-4-6-20(29)7-5-19)31-34(24)16-22(36)15-32-12-8-21(9-13-32)35-26(37)18-40-25-3-2-11-30-28(25)35/h2-7,11,21-22,36H,8-10,12-18H2,1H3 JBLOHPBDSXSVNC-UHFFFAOYSA-N 50182104 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one::CHEMBL377511 Cathepsin S Homo sapiens 68 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182104&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293657 104066894 CHEMBL377511 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337339 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrN5O4S/c1-40(37,38)33-18-13-25-24(19-33)29(21-7-9-22(30)10-8-21)31-34(25)15-4-14-32-16-11-23(12-17-32)35-26-5-2-3-6-27(26)39-20-28(35)36/h2-3,5-10,23H,4,11-20H2,1H3 AQQPFFXUJNSVOS-UHFFFAOYSA-N 50182105 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL383835 Cathepsin S Homo sapiens 60 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182105&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10304660 104066895 CHEMBL383835 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337340 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H35F3N6O4S/c1-44(42,43)37-15-12-27-25(19-37)28(20-6-8-22(9-7-20)30(31,32)33)35-38(27)18-24(40)17-36-13-10-23(11-14-36)39-26-5-3-2-4-21(26)16-34-29(39)41/h2-9,23-24,40H,10-19H2,1H3,(H,34,41) WYSKAEXCXYHGLH-UHFFFAOYSA-N 50182097 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one::CHEMBL208344 HLA class II histocompatibility antigen gamma chain Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182097&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293909 104066887 CHEMBL208344 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337341 Cc1cccc2OCC(=O)N(C3CCN(CCCn4nc(c5CN(CCc45)S(C)(=O)=O)-c4ccc(Br)cc4)CC3)c12 InChI=1S/C30H36BrN5O4S/c1-21-5-3-6-27-30(21)36(28(37)20-40-27)24-11-16-33(17-12-24)14-4-15-35-26-13-18-34(41(2,38)39)19-25(26)29(32-35)22-7-9-23(31)10-8-22/h3,5-10,24H,4,11-20H2,1-2H3 QQNJSLZFYGMUKV-UHFFFAOYSA-N 50182106 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-5-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL380361 HLA class II histocompatibility antigen gamma chain Homo sapiens 1600 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182106&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10233142 104066896 CHEMBL380361 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337342 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(Br)cc1 InChI=1S/C29H33BrClN5O5S/c1-42(39,40)34-13-10-25-24(17-34)29(19-2-4-20(30)5-3-19)32-35(25)16-23(37)15-33-11-8-22(9-12-33)36-26-14-21(31)6-7-27(26)41-18-28(36)38/h2-7,14,22-23,37H,8-13,15-18H2,1H3 SKERAAMRWSRRMF-UHFFFAOYSA-N 50182107 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-6-chloro-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL206067 HLA class II histocompatibility antigen gamma chain Homo sapiens 4400 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182107&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293870 104066897 CHEMBL206067 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337343 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2cc(Cl)ccc12)-c1ccc(Br)cc1 InChI=1S/C30H35BrClN5O4S/c1-42(40,41)35-15-12-28-26(19-35)30(20-2-5-22(31)6-3-20)33-36(28)18-25(38)17-34-13-10-24(11-14-34)37-27-8-7-23(32)16-21(27)4-9-29(37)39/h2-3,5-8,16,24-25,38H,4,9-15,17-19H2,1H3 QCVFWWFGAKRNHR-UHFFFAOYSA-N 50182108 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-6-chloro-3,4-dihydroquinolin-2(1H)-one::CHEMBL408418 HLA class II histocompatibility antigen gamma chain Homo sapiens 750 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182108&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10233559 104066898 CHEMBL408418 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337344 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2cc(Cl)ccc12)-c1ccc(Br)cc1 InChI=1S/C30H35BrClN5O4S/c1-42(40,41)35-15-12-28-26(19-35)30(20-2-5-22(31)6-3-20)33-36(28)18-25(38)17-34-13-10-24(11-14-34)37-27-8-7-23(32)16-21(27)4-9-29(37)39/h2-3,5-8,16,24-25,38H,4,9-15,17-19H2,1H3 QCVFWWFGAKRNHR-UHFFFAOYSA-N 50182108 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-6-chloro-3,4-dihydroquinolin-2(1H)-one::CHEMBL408418 Cathepsin S Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182108&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10233559 104066898 CHEMBL408418 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337345 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H36F3N5O4S/c1-44(42,43)37-17-14-28-26(20-37)30(22-6-9-23(10-7-22)31(32,33)34)35-38(28)19-25(40)18-36-15-12-24(13-16-36)39-27-5-3-2-4-21(27)8-11-29(39)41/h2-7,9-10,24-25,40H,8,11-20H2,1H3 KJDYMUXDHOISCN-UHFFFAOYSA-N 50182109 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one::CHEMBL379769 HLA class II histocompatibility antigen gamma chain Homo sapiens 1800 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182109&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10304727 104066899 CHEMBL379769 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337346 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34F3N5O4S/c1-43(40,41)36-18-13-25-24(19-36)29(21-7-9-22(10-8-21)30(31,32)33)34-37(25)15-4-14-35-16-11-23(12-17-35)38-26-5-2-3-6-27(26)42-20-28(38)39/h2-3,5-10,23H,4,11-20H2,1H3 OMDGGXZLVWQNQJ-UHFFFAOYSA-N 50182110 4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL204525 HLA class II histocompatibility antigen gamma chain Homo sapiens 950 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182110&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10121801 104066900 CHEMBL204525 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337347 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrN5O4S/c1-40(37,38)33-18-13-25-24(19-33)29(21-7-9-22(30)10-8-21)31-34(25)15-4-14-32-16-11-23(12-17-32)35-26-5-2-3-6-27(26)39-20-28(35)36/h2-3,5-10,23H,4,11-20H2,1H3 AQQPFFXUJNSVOS-UHFFFAOYSA-N 50182105 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL383835 HLA class II histocompatibility antigen gamma chain Homo sapiens 1600 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182105&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10304660 104066895 CHEMBL383835 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337348 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34F3N5O5S/c1-44(41,42)36-15-12-25-24(18-36)29(20-6-8-21(9-7-20)30(31,32)33)34-37(25)17-23(39)16-35-13-10-22(11-14-35)38-26-4-2-3-5-27(26)43-19-28(38)40/h2-9,22-23,39H,10-19H2,1H3 AMSFCNUCSFWCJW-UHFFFAOYSA-N 50182092 4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL201461 HLA class II histocompatibility antigen gamma chain Homo sapiens 410 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182092&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10168223 104066882 CHEMBL201461 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337349 CC(C)(C)OC(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C34H40F3N5O4/c1-33(2,3)46-32(44)40-20-15-27-26(21-40)31(23-9-11-24(12-10-23)34(35,36)37)38-41(27)17-6-16-39-18-13-25(14-19-39)42-28-7-4-5-8-29(28)45-22-30(42)43/h4-5,7-12,25H,6,13-22H2,1-3H3 DKBCAGVQZAJUSZ-UHFFFAOYSA-N 50182112 tert-butyl 1-(3-(4-(3-oxo-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)piperidin-1-yl)propyl)-3-(4-(trifluoromethyl)phenyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate::CHEMBL206594 Cathepsin S Homo sapiens 900 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182112&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44410374 104066902 CHEMBL206594 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337350 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C30H36BrN5O4S/c1-41(39,40)34-17-14-28-26(20-34)30(22-6-9-23(31)10-7-22)32-35(28)19-25(37)18-33-15-12-24(13-16-33)36-27-5-3-2-4-21(27)8-11-29(36)38/h2-7,9-10,24-25,37H,8,11-20H2,1H3 ZGOIFGITJRFQKU-UHFFFAOYSA-N 50182100 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one::CHEMBL208103 HLA class II histocompatibility antigen gamma chain Homo sapiens 2000 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182100&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10122216 104066890 CHEMBL208103 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337351 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2cc(Cl)ccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H35ClF3N5O4S/c1-45(43,44)38-15-12-28-26(19-38)30(20-2-5-22(6-3-20)31(33,34)35)36-39(28)18-25(41)17-37-13-10-24(11-14-37)40-27-8-7-23(32)16-21(27)4-9-29(40)42/h2-3,5-8,16,24-25,41H,4,9-15,17-19H2,1H3 FGUVGHPZGGMLJY-UHFFFAOYSA-N 50182113 6-chloro-1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one::CHEMBL377684 Cathepsin S Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182113&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 9831164 104066903 CHEMBL377684 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337352 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1CCc2ccccc2C1)-c1ccc(Br)cc1 InChI=1S/C30H38BrN5O3S/c1-40(38,39)35-17-13-29-28(21-35)30(23-6-8-25(31)9-7-23)32-36(29)20-27(37)19-33-14-11-26(12-15-33)34-16-10-22-4-2-3-5-24(22)18-34/h2-9,26-27,37H,10-21H2,1H3 MUMVAWLSJMWHJO-UHFFFAOYSA-N 50182111 1-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-3-(4-(3,4-dihydroisoquinolin-2(1H)-yl)piperidin-1-yl)propan-2-ol::CHEMBL446116 Cathepsin S Homo sapiens 1775 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182111&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44410054 104066901 CHEMBL446116 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337353 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(Br)cc1 InChI=1S/C29H33BrClN5O4S/c1-41(38,39)34-16-11-25-24(18-34)29(20-3-5-21(30)6-4-20)32-35(25)13-2-12-33-14-9-23(10-15-33)36-26-17-22(31)7-8-27(26)40-19-28(36)37/h3-8,17,23H,2,9-16,18-19H2,1H3 BNUKWTZNHHNSEF-UHFFFAOYSA-N 50182114 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-6-chloro-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL380541 HLA class II histocompatibility antigen gamma chain Homo sapiens 2600 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182114&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10305142 104066904 CHEMBL380541 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337354 CC(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H34F3N5O4/c1-20(40)37-15-12-26-25(18-37)30(21-6-8-22(9-7-21)31(32,33)34)35-38(26)17-24(41)16-36-13-10-23(11-14-36)39-27-4-2-3-5-28(27)43-19-29(39)42/h2-9,23-24,41H,10-19H2,1H3 SGSPOYZDDMQIAD-UHFFFAOYSA-N 50182087 4-(1-(3-(5-acetyl-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL205919 Cathepsin S Homo sapiens 120 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182087&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10304088 104066877 CHEMBL205919 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337355 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1c2ccccc2COCC1=O)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H36F3N5O5S/c1-45(42,43)37-15-12-28-26(18-37)30(21-6-8-23(9-7-21)31(32,33)34)35-38(28)17-25(40)16-36-13-10-24(11-14-36)39-27-5-3-2-4-22(27)19-44-20-29(39)41/h2-9,24-25,40H,10-20H2,1H3 LYFKQHVCRNURSR-UHFFFAOYSA-N 50182115 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)benzo[e][1,4]oxazepin-2(1H,3H,5H)-one::CHEMBL207003 Cathepsin S Homo sapiens 163 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182115&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293806 104066905 CHEMBL207003 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337356 Cc1cccc2OCC(=O)N(C3CCN(CCCn4nc(c5CN(CCc45)S(C)(=O)=O)-c4ccc(cc4)C(F)(F)F)CC3)c12 InChI=1S/C31H36F3N5O4S/c1-21-5-3-6-27-30(21)39(28(40)20-43-27)24-11-16-36(17-12-24)14-4-15-38-26-13-18-37(44(2,41)42)19-25(26)29(35-38)22-7-9-23(10-8-22)31(32,33)34/h3,5-10,24H,4,11-20H2,1-2H3 RESXFZPYLTYNJX-UHFFFAOYSA-N 50182094 5-methyl-4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL379351 Cathepsin S Homo sapiens 145 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182094&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10189472 104066884 CHEMBL379351 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337357 CC(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H34F3N5O3/c1-21(40)37-18-13-26-25(19-37)30(22-7-9-23(10-8-22)31(32,33)34)35-38(26)15-4-14-36-16-11-24(12-17-36)39-27-5-2-3-6-28(27)42-20-29(39)41/h2-3,5-10,24H,4,11-20H2,1H3 DXZBVPJKNGQDSA-UHFFFAOYSA-N 50182102 4-(1-(3-(5-acetyl-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL206745 Cathepsin S Homo sapiens 100 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182102&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10303703 104066892 CHEMBL206745 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337358 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)OCc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrN5O5S/c1-41(38,39)33-15-12-27-25(18-33)28(20-6-8-22(30)9-7-20)31-34(27)17-24(36)16-32-13-10-23(11-14-32)35-26-5-3-2-4-21(26)19-40-29(35)37/h2-9,23-24,36H,10-19H2,1H3 BWPUFYABFXWBBF-UHFFFAOYSA-N 50182116 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-1H-benzo[d][1,3]oxazin-2(4H)-one::CHEMBL379502 Cathepsin S Homo sapiens 133 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182116&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293772 104066906 CHEMBL379502 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337359 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2cc(Cl)ccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34ClF3N6O4S/c1-45(43,44)38-13-10-27-25(18-38)28(19-2-4-21(5-3-19)30(32,33)34)36-39(27)17-24(41)16-37-11-8-23(9-12-37)40-26-7-6-22(31)14-20(26)15-35-29(40)42/h2-7,14,23-24,41H,8-13,15-18H2,1H3,(H,35,42) PPNRZJCYXTWNEF-UHFFFAOYSA-N 50182117 6-chloro-1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one::CHEMBL377683 HLA class II histocompatibility antigen gamma chain Homo sapiens 1900 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182117&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10233451 104066907 CHEMBL377683 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337360 Cc1cccc2OCC(=O)N(C3CCN(CCCn4nc(c5CN(CCc45)S(C)(=O)=O)-c4ccc(Br)cc4)CC3)c12 InChI=1S/C30H36BrN5O4S/c1-21-5-3-6-27-30(21)36(28(37)20-40-27)24-11-16-33(17-12-24)14-4-15-35-26-13-18-34(41(2,38)39)19-25(26)29(32-35)22-7-9-23(31)10-8-22/h3,5-10,24H,4,11-20H2,1-2H3 QQNJSLZFYGMUKV-UHFFFAOYSA-N 50182106 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-5-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL380361 Cathepsin S Homo sapiens 170 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182106&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10233142 104066896 CHEMBL380361 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337361 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2cc(Cl)ccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H35ClF3N5O4S/c1-45(43,44)38-15-12-28-26(19-38)30(20-2-5-22(6-3-20)31(33,34)35)36-39(28)18-25(41)17-37-13-10-24(11-14-37)40-27-8-7-23(32)16-21(27)4-9-29(40)42/h2-3,5-8,16,24-25,41H,4,9-15,17-19H2,1H3 FGUVGHPZGGMLJY-UHFFFAOYSA-N 50182113 6-chloro-1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one::CHEMBL377684 HLA class II histocompatibility antigen gamma chain Homo sapiens 980 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182113&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 9831164 104066903 CHEMBL377684 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337362 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1c2ccc(Cl)cc2CNS1(=O)=O)-c1ccc(cc1)C(F)(F)F InChI=1S/C29H34ClF3N6O5S2/c1-45(41,42)37-13-10-27-25(18-37)28(19-2-4-21(5-3-19)29(31,32)33)35-38(27)17-24(40)16-36-11-8-23(9-12-36)39-26-7-6-22(30)14-20(26)15-34-46(39,43)44/h2-7,14,23-24,34,40H,8-13,15-18H2,1H3 XLBFTGSAZVJCHG-UHFFFAOYSA-N 50182101 1-[4-(6-Chloro-2,2-dioxo-3,4-dihydro-2H-2lambda*6*-benzo[1,2,6]thiadiazin-1-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol::CHEMBL203102 Cathepsin S Homo sapiens 30 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182101&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10233786 104066891 CHEMBL203102 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337363 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2cccnc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C29H33F3N6O5S/c1-44(41,42)36-14-10-24-23(17-36)27(19-4-6-20(7-5-19)29(30,31)32)34-37(24)16-22(39)15-35-12-8-21(9-13-35)38-26(40)18-43-25-3-2-11-33-28(25)38/h2-7,11,21-22,39H,8-10,12-18H2,1H3 ANFWDRBSMJXUMQ-UHFFFAOYSA-N 50182098 4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one::CHEMBL239179 HLA class II histocompatibility antigen gamma chain Homo sapiens 1300 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182098&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10233020 104066888 CHEMBL239179 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337364 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrN5O5S/c1-41(38,39)33-15-12-25-24(18-33)29(20-6-8-21(30)9-7-20)31-34(25)17-23(36)16-32-13-10-22(11-14-32)35-26-4-2-3-5-27(26)40-19-28(35)37/h2-9,22-23,36H,10-19H2,1H3 BPDCKDZNPOCBFW-UHFFFAOYSA-N 50182118 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL406247 Cathepsin S Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182118&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10282988 104066908 CHEMBL406247 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337365 FC(F)(F)c1ccc(cc1)-c1nn(CCCN2CCC(CC2)N2C(=O)COc3ccccc23)c2CCNCc12 InChI=1S/C29H32F3N5O2/c30-29(31,32)21-8-6-20(7-9-21)28-23-18-33-13-10-24(23)36(34-28)15-3-14-35-16-11-22(12-17-35)37-25-4-1-2-5-26(25)39-19-27(37)38/h1-2,4-9,22,33H,3,10-19H2 NGIKJKVCHFIMFL-UHFFFAOYSA-N 50182119 4-(1-(3-(3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL205631 Cathepsin S Homo sapiens 1800 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182119&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293715 104066909 CHEMBL205631 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337366 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)CCc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H36F3N5O4S/c1-44(42,43)37-17-14-28-26(20-37)30(22-6-9-23(10-7-22)31(32,33)34)35-38(28)19-25(40)18-36-15-12-24(13-16-36)39-27-5-3-2-4-21(27)8-11-29(39)41/h2-7,9-10,24-25,40H,8,11-20H2,1H3 KJDYMUXDHOISCN-UHFFFAOYSA-N 50182109 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one::CHEMBL379769 Cathepsin S Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182109&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10304727 104066899 CHEMBL379769 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337367 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(Br)cc1 InChI=1S/C29H33BrClN5O4S/c1-41(38,39)34-16-11-25-24(18-34)29(20-3-5-21(30)6-4-20)32-35(25)13-2-12-33-14-9-23(10-15-33)36-26-17-22(31)7-8-27(26)40-19-28(36)37/h3-8,17,23H,2,9-16,18-19H2,1H3 BNUKWTZNHHNSEF-UHFFFAOYSA-N 50182114 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-6-chloro-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL380541 Cathepsin S Homo sapiens 130 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182114&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10305142 104066904 CHEMBL380541 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337368 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H33ClF3N5O5S/c1-45(42,43)37-13-10-25-24(17-37)29(19-2-4-20(5-3-19)30(32,33)34)35-38(25)16-23(40)15-36-11-8-22(9-12-36)39-26-14-21(31)6-7-27(26)44-18-28(39)41/h2-7,14,22-23,40H,8-13,15-18H2,1H3 PXKDEJBONDAVII-UHFFFAOYSA-N 50182103 6-chloro-4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL414587 HLA class II histocompatibility antigen gamma chain Homo sapiens 1300 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182103&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10211864 104066893 CHEMBL414587 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337369 CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34F3N5O4S/c1-43(40,41)36-18-13-25-24(19-36)29(21-7-9-22(10-8-21)30(31,32)33)34-37(25)15-4-14-35-16-11-23(12-17-35)38-26-5-2-3-6-27(26)42-20-28(38)39/h2-3,5-10,23H,4,11-20H2,1H3 OMDGGXZLVWQNQJ-UHFFFAOYSA-N 50182110 4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL204525 Cathepsin S Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182110&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10121801 104066900 CHEMBL204525 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337370 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H34BrN5O5S/c1-41(38,39)33-15-12-25-24(18-33)29(20-6-8-21(30)9-7-20)31-34(25)17-23(36)16-32-13-10-22(11-14-32)35-26-4-2-3-5-27(26)40-19-28(35)37/h2-9,22-23,36H,10-19H2,1H3 BPDCKDZNPOCBFW-UHFFFAOYSA-N 50182118 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL406247 HLA class II histocompatibility antigen gamma chain Homo sapiens 1800 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182118&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 10282988 104066908 CHEMBL406247 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6 50337371 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C29H35BrN6O4S/c1-41(39,40)34-15-12-27-25(19-34)28(20-6-8-22(30)9-7-20)32-35(27)18-24(37)17-33-13-10-23(11-14-33)36-26-5-3-2-4-21(26)16-31-29(36)38/h2-9,23-24,37H,10-19H2,1H3,(H,31,38) AFUFPTUEAKAICH-UHFFFAOYSA-N 50182095 1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one::CHEMBL205748 Cathepsin S Homo sapiens 65 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182095&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293696 104066885 CHEMBL205748 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337372 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)NCc2cc(Cl)ccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34ClF3N6O4S/c1-45(43,44)38-13-10-27-25(18-38)28(19-2-4-21(5-3-19)30(32,33)34)36-39(27)17-24(41)16-37-11-8-23(9-12-37)40-26-7-6-22(31)14-20(26)15-35-29(40)42/h2-7,14,23-24,41H,8-13,15-18H2,1H3,(H,35,42) PPNRZJCYXTWNEF-UHFFFAOYSA-N 50182117 6-chloro-1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one::CHEMBL377683 Cathepsin S Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182117&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10233451 104066907 CHEMBL377683 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337373 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)OCc2ccccc12)-c1ccc(cc1)C(F)(F)F InChI=1S/C30H34F3N5O5S/c1-44(41,42)36-15-12-27-25(18-36)28(20-6-8-22(9-7-20)30(31,32)33)34-37(27)17-24(39)16-35-13-10-23(11-14-35)38-26-5-3-2-4-21(26)19-43-29(38)40/h2-9,23-24,39H,10-19H2,1H3 CPKFDNOZJRILFT-UHFFFAOYSA-N 50182093 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-1H-benzo[d][1,3]oxazin-2(4H)-one::CHEMBL381369 Cathepsin S Homo sapiens 88 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182093&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293649 104066883 CHEMBL381369 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337374 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1CCCc2ccccc12)-c1ccc(Br)cc1 InChI=1S/C30H38BrN5O3S/c1-40(38,39)34-18-14-29-27(21-34)30(23-8-10-24(31)11-9-23)32-36(29)20-26(37)19-33-16-12-25(13-17-33)35-15-4-6-22-5-2-3-7-28(22)35/h2-3,5,7-11,25-26,37H,4,6,12-21H2,1H3 QGFWMCFQLODLJF-UHFFFAOYSA-N 50182120 1-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-3-(4-(3,4-dihydroquinolin-1(2H)-yl)piperidin-1-yl)propan-2-ol::CHEMBL208131 Cathepsin S Homo sapiens 322 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182120&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44410036 104066910 CHEMBL208131 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337375 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)COc2ccc(Cl)cc12)-c1ccc(Br)cc1 InChI=1S/C29H33BrClN5O5S/c1-42(39,40)34-13-10-25-24(17-34)29(19-2-4-20(30)5-3-19)32-35(25)16-23(37)15-33-11-8-22(9-12-33)36-26-14-21(31)6-7-27(26)41-18-28(36)38/h2-7,14,22-23,37H,8-13,15-18H2,1H3 SKERAAMRWSRRMF-UHFFFAOYSA-N 50182107 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-6-chloro-2H-benzo[b][1,4]oxazin-3(4H)-one::CHEMBL206067 Cathepsin S Homo sapiens 48 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182107&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 22293870 104066897 CHEMBL206067 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50337376 CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1c2ccccc2COCC1=O)-c1ccc(cc1)C(F)(F)F InChI=1S/C31H36F3N5O5S/c1-45(42,43)37-15-12-28-26(18-37)30(21-6-8-23(9-7-21)31(32,33)34)35-38(28)17-25(40)16-36-13-10-24(11-14-36)39-27-5-3-2-4-22(27)19-44-20-29(39)41/h2-9,24-25,40H,10-20H2,1H3 LYFKQHVCRNURSR-UHFFFAOYSA-N 50182115 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)benzo[e][1,4]oxazepin-2(1H,3H,5H)-one::CHEMBL207003 HLA class II histocompatibility antigen gamma chain Homo sapiens 930 ChEMBL 10.1016/j.bmcl.2006.01.038 10.7270/Q2K35T7W 16458510 Grice, CA; Tays, K; Khatuya, H; Gustin, DJ; Butler, CR; Wei, J; Sehon, CA; Sun, S; Gu, Y; Jiang, W; Thurmond, RL; Karlsson, L; Edwards, JP 3/10/2006 11/10/2009 Johnson and Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50182115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003505&target=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50182115&enzyme=HLA+class+II+histocompatibility+antigen+gamma+chain&column=ki&startPg=0&Increment=50&submit=Search 22293806 104066905 CHEMBL207003 1 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM 8VSP,8VRW,1IIE,1L3H,1ICF,3PDO,7YXB,7Z0Q,9CYM,9CYL,8VSJ,7YX9,5KSU,3QXD,3QXA,1A6A,3PGD,3PGC,4AEN,5KSV,4AH2 HLA class II histocompatibility antigen gamma chain HG2A_HUMAN P04233 A8K7R1 B4DNE8 D3DQG3 D3DQG4 Q14597 Q29832 Q5U0J8 Q8SNA0 Q8WLP6